Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001055884 | SCV001220298 | pathogenic | MPI-congenital disorder of glycosylation | 2023-12-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg56*) in the MPI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPI are known to be pathogenic (PMID: 19862844). This variant is present in population databases (rs757168691, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MPI-related conditions. ClinVar contains an entry for this variant (Variation ID: 851479). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001055884 | SCV004193279 | likely pathogenic | MPI-congenital disorder of glycosylation | 2024-02-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001055884 | SCV005633252 | likely pathogenic | MPI-congenital disorder of glycosylation | 2024-05-17 | criteria provided, single submitter | clinical testing |